CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in prevalence of cardiovascular diseases.
3.4.1.2. Unhealthy diet and modern sedentary lifestyle.
3.4.1.3. Rise in geriatric population.
3.4.2. Restraints
3.4.2.1. High cost of coronary artery bypass graft devices.
3.4.3. Opportunities
3.4.3.1. Rise in awareness about heart health
CHAPTER 4: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Off pump CABG
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. On pump CABG
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Minimally invasive CABG
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Cardiopulmonary Bypass Machines
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Endoscopic Vessel Harvesting Systems
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Heart Positioners
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Tissue Stabilizer
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Cardiac Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Technology
7.2.3. Market size and forecast, by Product
7.2.4. Market size and forecast, by End Users
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Technology
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by End Users
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Technology
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by End Users
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Technology
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by End Users
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Technology
7.3.3. Market size and forecast, by Product
7.3.4. Market size and forecast, by End Users
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Technology
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by End Users
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Technology
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by End Users
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Technology
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by End Users
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Technology
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by End Users
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Technology
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by End Users
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Technology
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by End Users
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Technology
7.4.3. Market size and forecast, by Product
7.4.4. Market size and forecast, by End Users
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Technology
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by End Users
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Technology
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by End Users
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Technology
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by End Users
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Technology
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by End Users
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Technology
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by End Users
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Technology
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by End Users
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Technology
7.5.3. Market size and forecast, by Product
7.5.4. Market size and forecast, by End Users
7.5.5. Market size and forecast, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by Technology
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by End Users
7.5.5.2. Middle East And Africa
7.5.5.2.1. Market size and forecast, by Technology
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by End Users
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Baxter International Inc.
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Terumo Corporation
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Peters Surgical Group
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Getinge AB
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Genesee Biomedical Inc
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Transonic Systems Inc.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Livanova, Plc
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Condor MedTec GmbH
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Saphena Medical, Inc.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/